What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Enzyme
Jean-Jacques Fournié mainly focuses on T cell, Immunology, Cell biology, Antigen and T-cell receptor.
His T cell study deals with the bigger picture of Immune system.
He combines subjects such as Cytotoxic T cell and Tyrosine kinase with his study of Immunology.
The Cell biology study combines topics in areas such as Interleukin 21 and Cellular model.
His studies in Antigen integrate themes in fields like Biochemistry, Interleukin 17 and Virology.
His research in T-cell receptor intersects with topics in Agonist, Toxicity, Mevalonate pathway and Mechanism of action.
His most cited work include:
- Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands (627 citations)
- Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast Cancer (260 citations)
- Structure of a human gammadelta T-cell antigen receptor. (215 citations)
What are the main themes of his work throughout his whole career to date?
Jean-Jacques Fournié spends much of his time researching Immunology, T cell, Cancer research, Immune system and Antigen.
His studies deal with areas such as Cytotoxic T cell and Cancer as well as Immunology.
Jean-Jacques Fournié studies T cell, focusing on T-cell receptor in particular.
His T-cell receptor research includes elements of Cell biology, Effector and T lymphocyte.
In his research, Transcriptome is intimately related to Lymphoma, which falls under the overarching field of Cancer research.
His study focuses on the intersection of Antigen and fields such as Glycolipid with connections in the field of Stereochemistry.
He most often published in these fields:
- Immunology (44.48%)
- T cell (30.60%)
- Cancer research (23.84%)
What were the highlights of his more recent work (between 2013-2021)?
- Cancer research (23.84%)
- Immune system (23.84%)
- Immunology (44.48%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Immune system, Immunology, Immunotherapy and Immune checkpoint.
His Cancer research study incorporates themes from Cancer cell, Reprogramming, Tumor microenvironment, Macrophage and Effector.
The study incorporates disciplines such as Receptor and Follicular lymphoma in addition to Immune system.
His Immunology research integrates issues from Phenotype, Cancer and Cytotoxic T cell.
His Cytotoxic T cell course of study focuses on T-cell receptor and Cell biology, T lymphocyte, Interleukin 2 and In vitro.
His study looks at the relationship between Immunotherapy and topics such as T cell, which overlap with Cell.
Between 2013 and 2021, his most popular works were:
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays (53 citations)
- Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer. (51 citations)
- Several immune escape patterns in non-Hodgkin's lymphomas (51 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Enzyme
His primary scientific interests are in Immunology, Cancer research, Chronic lymphocytic leukemia, Immune system and Tumor microenvironment.
He interconnects Cytotoxic T cell, Transcriptome and Peripheral blood mononuclear cell in the investigation of issues within Immunology.
In his study, which falls under the umbrella issue of Cytotoxic T cell, Cell is strongly linked to T-cell receptor.
Cytokine is closely connected to Antigen in his research, which is encompassed under the umbrella topic of Transcriptome.
His work in Cancer research tackles topics such as Immunotherapy which are related to areas like Interleukin 21, Monocyte and Cytotoxicity.
His work investigates the relationship between Follicular lymphoma and topics such as Cell cycle that intersect with problems in Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
